{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T07:25:42Z","timestamp":1769066742424,"version":"3.49.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T00:00:00Z","timestamp":1625788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016187","name":"Newlife the Charity for Disabled Children","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016187","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/L002744\/1"],"award-info":[{"award-number":["MR\/L002744\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/T016809\/1"],"award-info":[{"award-number":["MR\/T016809\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000291","name":"Kidney Research UK","doi-asserted-by":"publisher","award":["Paed_RP_002_20190925"],"award-info":[{"award-number":["Paed_RP_002_20190925"]}],"id":[{"id":"10.13039\/501100000291","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000291","name":"Kidney Research UK","doi-asserted-by":"publisher","award":["RP_018_20170302"],"award-info":[{"award-number":["RP_018_20170302"]}],"id":[{"id":"10.13039\/501100000291","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpurol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric Urology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.jpurol.2021.07.002","type":"journal-article","created":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T14:38:20Z","timestamp":1625668700000},"page":"610-620","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Envisioning treating genetically-defined urinary tract malformations with viral vector-mediated gene therapy"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9913-4137","authenticated-orcid":false,"given":"Filipa M.","family":"Lopes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5541-1358","authenticated-orcid":false,"given":"Adrian S.","family":"Woolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6955-5536","authenticated-orcid":false,"given":"Neil A.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpurol.2021.07.002_bib1","unstructured":"EU research on rare diseases. https:\/\/ec.europa.eu\/info\/research-and-innovation\/research-area\/health-research-and-innovation\/rare-diseases_en. [Accessed 12 October 2020]."},{"key":"10.1016\/j.jpurol.2021.07.002_bib2","unstructured":"Rare diseases at FDA. https:\/\/www.fda.gov\/patients\/rare-diseases-fda. [Accessed 12 October 2020]."},{"key":"10.1016\/j.jpurol.2021.07.002_bib3","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00467-011-1939-1","article-title":"Epidemiology of chronic kidney disease in children","volume":"27","author":"Harambat","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jpurol.2021.07.002_bib4","unstructured":"Kidney disease statistics for the United States. https:\/\/www.niddk.nih.gov\/health-information\/health-statistics\/kidney-disease. [Accessed 12 October 2020]."},{"key":"10.1016\/j.jpurol.2021.07.002_bib5","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1007\/s00467-008-1108-3","article-title":"What do we know about chronic renal failure in young adults?","volume":"24","author":"Neild","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jpurol.2021.07.002_bib6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00404-001-0265-4","article-title":"Malformations in newborn: results based on 30940 infants and fetuses from the Mainz congenital birth defect monitoring system (1990-1998)","volume":"266","author":"Quei\u00dfer-Luft","year":"2002","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.jpurol.2021.07.002_bib7","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1007\/s00467-010-1578-y","article-title":"Renal malformations associated with mutations of developmental genes: messages from the clinic","volume":"25","author":"Adalat","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jpurol.2021.07.002_bib8","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrneph.2014.232","article-title":"HNF1B-associated renal and extra-renal disease","volume":"11","author":"Clissold","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jpurol.2021.07.002_bib9","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.ekir.2019.05.019","article-title":"HNF1B mutations are associated with a Gitelman-like tubulopathy that develops during childhood","volume":"4","author":"Adalat","year":"2019","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.jpurol.2021.07.002_bib10","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3389\/fped.2019.00136","article-title":"Congenital disorders of the human urinary tract: recent insights from genetic and molecular studies","volume":"7","author":"Woolf","year":"2019","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jpurol.2021.07.002_bib11","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1681\/ASN.2004090776","article-title":"De novo Uroplakin IIIa mutations cause renal adysplasia leading to severe kidney failure","volume":"16","author":"Jenkins","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jpurol.2021.07.002_bib12","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1053\/j.ajkd.2006.02.177","article-title":"Mutations in Uroplakin IIIA are a rare cause of renal hypodysplasia in humans","volume":"47","author":"Sch\u00f6nfelder","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jpurol.2021.07.002_bib13","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1093\/ndt\/gfl465","article-title":"Mutation analyses of Uroplakin II in children with renal tract malformations","volume":"21","author":"Jenkins","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jpurol.2021.07.002_bib14","doi-asserted-by":"crossref","first-page":"5374","DOI":"10.1172\/JCI128545","article-title":"Loss-of-function variants in myocardin cause congenital megabladder in humans and mice","volume":"129","author":"Houweling","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jpurol.2021.07.002_bib15","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jpurol.2006.01.019","article-title":"Experimental short-term fetal bladder outflow obstruction. I. Morphology and cell biology associated with urinary flow impairment","volume":"2","author":"Farrugia","year":"2006","journal-title":"J Pediatr Urol"},{"key":"10.1016\/j.jpurol.2021.07.002_bib16","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/ng.3681","article-title":"TSHZ3 deletion causes an autism syndrome and defects in cortical projection neurons","volume":"48","author":"Caubit","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.jpurol.2021.07.002_bib17","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1242\/dev.022442","article-title":"Teashirt 3 is necessary for ureteral smooth muscle differentiation downstream of SHH and BMP4","volume":"135","author":"Caubit","year":"2008","journal-title":"Development"},{"key":"10.1016\/j.jpurol.2021.07.002_bib18","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/ndt\/gfp453","article-title":"Analysis of TSHZ2 and TSHZ3 genes in congenital pelvi-ureteric junction obstruction","volume":"25","author":"Jenkins","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jpurol.2021.07.002_bib19","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ajhg.2011.10.007","article-title":"Muscarinic acetylcholine receptor M3 mutation causes urinary bladder disease and a prune-belly-like syndrome","volume":"89","author":"Weber","year":"2011","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jpurol.2021.07.002_bib20","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/cge.13631","article-title":"A homozygous missense variant in CHRM3 associated with familial urinary bladder disease","volume":"96","author":"Beaman","year":"2019","journal-title":"Clin Genet"},{"key":"10.1016\/j.jpurol.2021.07.002_bib21","series-title":"GeneReviews\u00ae [Internet]","first-page":"1993","article-title":"Urofacial syndrome","author":"Newman","year":"2013"},{"key":"10.1016\/j.jpurol.2021.07.002_bib22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ajhg.2012.12.002","article-title":"LRIG2 mutations cause urofacial syndrome","volume":"92","author":"Stuart","year":"2013","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jpurol.2021.07.002_bib23","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.ajhg.2019.03.023","article-title":"Rare variants in BNC2 are implicated in autosomal dominant congenital lower urinary tract obstruction","volume":"104","author":"Kolvenbach","year":"2019","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jpurol.2021.07.002_bib24","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12881-020-0973-x","article-title":"Prune belly syndrome in surviving males can be caused by hemizygous missense mutations in the X-linked filamin A gene","volume":"21","author":"Iqbal","year":"2020","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.jpurol.2021.07.002_bib25","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3389\/fcell.2020.00567","article-title":"SLC20A1 is involved in urinary tract and urorectal development","volume":"8","author":"Rieke","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jpurol.2021.07.002_bib26","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.ekir.2020.07.001","article-title":"Early B-cell factor 3-related genetic disease mimics urofacial syndrome","volume":"5","author":"Harkness","year":"2020","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.jpurol.2021.07.002_bib27","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1038\/s41436-020-0918-y","article-title":"Application of exome sequencing for prenatal diagnosis: a rapid scoping review","volume":"22","author":"Pratt","year":"2020","journal-title":"Genet Med"},{"key":"10.1016\/j.jpurol.2021.07.002_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-15062-9","article-title":"Genome-wide linkage and association study implicates the 10q26 region as a major genetic contributor to primary nonsyndromic vesicoureteric reflux","volume":"7","author":"Darlow","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jpurol.2021.07.002_bib29","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1681\/ASN.2008111206","article-title":"Ureter myogenesis: putting Teashirt into context","volume":"21","author":"Lye","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jpurol.2021.07.002_bib30","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.kint.2018.11.040","article-title":"Lrig2 and Hpse2, mutated in urofacial syndrome, pattern nerves in the urinary bladder","volume":"95","author":"Roberts","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.jpurol.2021.07.002_bib31","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1083\/jcb.151.5.961","article-title":"Ablation of uroplakin III gene results in small urothelial plaques, urothelial leakage, and vesicoureteral reflux","volume":"151","author":"Hu","year":"2000","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jpurol.2021.07.002_bib32","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1083\/jcb.200406025","article-title":"Roles of uroplakins in plaque formation, umbrella cell enlargement, and urinary tract diseases","volume":"167","author":"Kong","year":"2004","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jpurol.2021.07.002_bib33","doi-asserted-by":"crossref","first-page":"F387","DOI":"10.1152\/ajprenal.00185.2010","article-title":"Temporally and spatially controllable gene expression and knockout in mouse urothelium","volume":"299","author":"Zhou","year":"2010","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.jpurol.2021.07.002_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053675","article-title":"Analysis of the sonic hedgehog signaling pathway in normal and abnormal bladder development","volume":"8","author":"DeSouza","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jpurol.2021.07.002_bib35","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/978-1-61779-851-1_34","article-title":"Urinary diversion via cutaneous vesicostomy in the megabladder mouse","volume":"886","author":"Carpenter","year":"2012","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jpurol.2021.07.002_bib36","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1681\/ASN.2006040405","article-title":"Identification of a unique transgenic mouse line that develops megabladder, obstructive uropathy, and renal dysfunction","volume":"18","author":"Singh","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jpurol.2021.07.002_bib37","doi-asserted-by":"crossref","first-page":"9579","DOI":"10.1073\/pnas.97.17.9579","article-title":"Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype","volume":"97","author":"Matsui","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jpurol.2021.07.002_bib38","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1097\/01.ju.0000138054.77785.4a","article-title":"Cystometric findings in mice lacking muscarinic M2 or M3 receptors","volume":"172","author":"Igawa","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2021.07.002_bib39","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1681\/ASN.2013090961","article-title":"Urinary tract effects of HPSE2 mutations","volume":"26","author":"Stuart","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jpurol.2021.07.002_bib40","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1002\/nau.24450","article-title":"Dysfunctional bladder neurophysiology in urofacial syndrome Hpse2 mutant mice","volume":"39","author":"Manak","year":"2020","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.jpurol.2021.07.002_bib41","first-page":"41","article-title":"Gene transfer into the mammalian kidney: micro-transplantation of retrovirus-transduced metanephric tissue","volume":"1","author":"Woolf","year":"1993","journal-title":"Exp Nephrol"},{"key":"10.1016\/j.jpurol.2021.07.002_bib42","first-page":"49","article-title":"Gene transfer into the mammalian kidney: direct retrovirus transduction of regenerating tubular epithelial cells","volume":"1","author":"Bosch","year":"1993","journal-title":"Exp Nephrol"},{"key":"10.1016\/j.jpurol.2021.07.002_bib43","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMra1706910","article-title":"Gene therapy","volume":"381","author":"High","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpurol.2021.07.002_bib44","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-dose gene-replacement therapy for spinal muscular atrophy","volume":"377","author":"Mendell","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpurol.2021.07.002_bib45","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa1407309","article-title":"Long-term safety and efficacy of factor IX gene therapy in hemophilia B","volume":"371","author":"Nathwani","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpurol.2021.07.002_bib46","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1089\/hum.2020.182","article-title":"Moving forward after two deaths in a gene therapy trial of myotubular myopathy","volume":"31","author":"Wilson","year":"2020","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.jpurol.2021.07.002_bib47","doi-asserted-by":"crossref","first-page":"403e12","DOI":"10.1089\/hum.2017.203","article-title":"Biology of the adrenal gland cortex obviates effective use of adeno-associated virus vectors to treat hereditary adrenal disorders","volume":"29","author":"Markmann","year":"2018","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.jpurol.2021.07.002_bib48","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41587-020-0741-7","article-title":"A long-term study of AAV gene therapy in dogs with hemophilia A identifies clonal expansions of transduced liver cells","volume":"39","author":"Nguyen","year":"2021","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jpurol.2021.07.002_bib49","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nbt.1515","article-title":"Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes","volume":"27","author":"Foust","year":"2009","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jpurol.2021.07.002_bib50","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nbt.1610","article-title":"Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN","volume":"28","author":"Foust","year":"2010","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jpurol.2021.07.002_bib51","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/nmo.12724","article-title":"Proof-of-concept: neonatal intravenous injection of AAV vectors results in successful transduction of myenteric and submucosal neurons in the mouse small and large intestine","volume":"28","author":"Buckinx","year":"2016","journal-title":"Neuro Gastroenterol Motil"},{"key":"10.1016\/j.jpurol.2021.07.002_bib52","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/s41591-018-0106-7","article-title":"Fetal gene therapy for neurodegenerative disease of infants","volume":"24","author":"Massaro","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.jpurol.2021.07.002_bib53","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1038\/s41467-018-05972-1","article-title":"Argininosuccinic aciduria fosters neuronal nitrosative stress reversed by Asl gene transfer","volume":"9","author":"Baruteau","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jpurol.2021.07.002_bib54","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/gt.2017.18","article-title":"Efficient CNS targeting in adult mice by intrathecal infusion of single-stranded AAV9-GFP for gene therapy of neurological disorders","volume":"24","author":"Bey","year":"2017","journal-title":"Gene Ther"},{"key":"10.1016\/j.jpurol.2021.07.002_bib55","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2014.14","article-title":"Kidney-specific expression of GFP by in-utero delivery of pseudotyped adeno-associated virus 9","volume":"1","author":"Picconi","year":"2014","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.jpurol.2021.07.002_bib56","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ymthe.2019.02.015","article-title":"In utero gene therapy consensus statement from the IFeTIS","volume":"27","author":"Almeida-Porada","year":"2019","journal-title":"Mol Ther"},{"key":"10.1016\/j.jpurol.2021.07.002_bib57","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/pd.5267","article-title":"The legal frameworks that govern fetal surgery in the United Kingdom, European Union, and the United States","volume":"38","author":"Cao","year":"2018","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jpurol.2021.07.002_bib58","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/uog.15880","article-title":"Ethics and social acceptability of a proposed clinical trial using maternal gene therapy to treat severe early-onset fetal growth restriction","volume":"47","author":"Sheppard","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jpurol.2021.07.002_bib59","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1056\/NEJMoa1714322","article-title":"Prenatal correction of X-linked hypohidrotic ectodermal dysplasia","volume":"378","author":"Schneider","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpurol.2021.07.002_bib60","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1096\/fj.11-182311","article-title":"Intravenous administration of AAV2\/9 to the fetal and neonatal mouse leads to differential targeting of CNS cell types and extensive transduction of the nervous system","volume":"25","author":"Rahim","year":"2011","journal-title":"FASEB J"},{"key":"10.1016\/j.jpurol.2021.07.002_bib61","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1096\/fj.14-269092","article-title":"Systemic gene delivery following intravenous administration of AAV9 to fetal and neonatal mice and late-gestation nonhuman primates","volume":"29","author":"Mattar","year":"2015","journal-title":"FASEB J"},{"key":"10.1016\/j.jpurol.2021.07.002_bib62","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3390\/genes10030218","article-title":"Lentiviral vectors for the treatment and prevention of cystic fibrosis lung disease","volume":"10","author":"Marquez","year":"2019","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.jpurol.2021.07.002_bib63","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jconrel.2017.12.029","article-title":"High-efficiency transduction of spinal cord motor neurons by intrauterine delivery of integration-deficient lentiviral vectors","volume":"273","author":"Ahmed","year":"2018","journal-title":"J Control Release"},{"key":"10.1016\/j.jpurol.2021.07.002_bib64","article-title":"In utero gene therapy (IUGT) using GLOBE lentiviral vector phenotypically corrects the heterozygous humanised mouse model and its progress can be monitored using MRI techniques","volume":"9","author":"Shangaris","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jpurol.2021.07.002_bib65","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1152\/physiolgenomics.00052.2019","article-title":"Gene therapy research for kidney disease","volume":"51","author":"Davis","year":"2019","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.jpurol.2021.07.002_bib66","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S0002-9440(10)63923-5","article-title":"Urinary outflow obstruction increases apoptosis and degregulates Bcl-2 and Bax expression in the fetal ovine bladder","volume":"162","author":"Thiruchelvam","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jpurol.2021.07.002_bib67","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/S0140-6736(13)60992-7","article-title":"Percutaneous vesicoamniotic shunting versus conservative management for fetal lower urinary tract obstruction (PLUTO): a randomised trial","volume":"382","author":"Morris","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jpurol.2021.07.002_bib68","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-012360","article-title":"Healthcare resource consumption for intermittent urinary catheterisation","volume":"7","author":"Rognoni","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.jpurol.2021.07.002_bib69","series-title":"UK renal research strategy","first-page":"1","author":"Karet Frankl","year":"2016"},{"key":"10.1016\/j.jpurol.2021.07.002_bib70","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/sj.cgt.7700488","article-title":"Syn3 provides high levels of intravesical adenoviral-mediated gene transfer for gene therapy of genetically altered urothelium and superficial bladder cancer","volume":"9","author":"Yamashita","year":"2002","journal-title":"Canc Gene Ther"},{"key":"10.1016\/j.jpurol.2021.07.002_bib71","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/nau.24272","volume":"39","author":"Rovner","year":"2020","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.jpurol.2021.07.002_bib72","unstructured":"Cell and gene therapy clinical trials (catapult.org.uk). https:\/\/ct.catapult.org.uk\/clinical-trials-database. [Accessed 20 May 2021]."},{"key":"10.1016\/j.jpurol.2021.07.002_bib73","unstructured":"https:\/\/pharmaphorum.com\/news\/novartis-reimbursement-options-as-eu-approves-ultra-pricey-sma-drug\/#:\u223c:text=But%20Zolgensma%20is%20also%20the,costs%20further%20down%20the%20line. [Accessed 27 January 2021]."},{"key":"10.1016\/j.jpurol.2021.07.002_bib74","unstructured":"https:\/\/www.technologyreview.com\/2017\/04\/21\/152385\/the-worlds-most-expensive-medicine-is-being-pulled-from-the-market\/#:\u223c:text=The%20drug%2C%20Glybera%2C%20was%20the,deficiency%2C%20a%20rare%20metabolic%20disease. [Accessed 27 January 2021]."},{"key":"10.1016\/j.jpurol.2021.07.002_bib75","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1093\/hmg\/ddz148","article-title":"Next-generation AAV vectors-do not judge a virus (only) by its cover","volume":"28","author":"Domenger","year":"2019","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jpurol.2021.07.002_bib76","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ymthe.2020.01.001","article-title":"Immune responses to viral gene therapy vectors","volume":"28","author":"Shirley","year":"2020","journal-title":"Mol Ther"}],"container-title":["Journal of Pediatric Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477513121003399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477513121003399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:50:19Z","timestamp":1761486619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477513121003399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":76,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S1477513121003399"],"URL":"https:\/\/doi.org\/10.1016\/j.jpurol.2021.07.002","relation":{},"ISSN":["1477-5131"],"issn-type":[{"value":"1477-5131","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Envisioning treating genetically-defined urinary tract malformations with viral vector-mediated gene therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpurol.2021.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd on behalf of Journal of Pediatric Urology Company.","name":"copyright","label":"Copyright"}]}}